Patents by Inventor Douglas L. Coleman

Douglas L. Coleman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4666898
    Abstract: Obesity, diabetes obesity syndromes and associated hypercorticoidism are treated with .alpha. and/or .beta.-etiocholanolone.
    Type: Grant
    Filed: December 19, 1984
    Date of Patent: May 19, 1987
    Assignees: Jackson Lab., Progenics, Inc.
    Inventors: Douglas L. Coleman, Norman Applezweig
  • Patent number: 4518595
    Abstract: Diabetes is treated by orally administering a dehydroepiandrosterone (DHEA) compound selected from the group consisting of DHEA, DHEA sulfate and soluble DHEA compounds. The DHEA compound is preferably administered in finely dispersed form, powdered or solution, mixed with the food diet of the diabetic in a dosage range of up to 0.4% by weight of the food diet. The pharmacological activity and utility of DHEA as a potent anti-diabetic agent and anti-hyperglycemic agent over a variable range of genetic background is documented.
    Type: Grant
    Filed: July 19, 1983
    Date of Patent: May 21, 1985
    Assignee: The Jackson Laboratory
    Inventors: Douglas L. Coleman, Norman Applezweig, Edward H. Leiter
  • Patent number: 4507289
    Abstract: Diabetes obesity syndromes and associated hypercorticoidism are treated with a synergistic combination of .alpha.- and/or .beta.-etiocholanolone and an estrogen.
    Type: Grant
    Filed: December 28, 1983
    Date of Patent: March 26, 1985
    Assignees: Progenics, Inc., The Jackson Laboratory
    Inventors: Douglas L. Coleman, Norman Applezweig